https://doi.org/10.4081/aiua.2026.14858
Treatment with Hippo/YAP pathway modulators partially improves testicular and sperm phenotypes following cisplatin stimulation
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 22 June 2026
Background: Treatment with chemotherapeutic agents often causes side effects in male reproductive organs, which may lead to infertility. Identification of molecular targets to alleviate this effect is important to reduce the long-term effects of chemotherapeutic drugs on the reproductive capacity. In this study, we evaluated the effects of pharmacological targeting of the Hippo pathway on the male reproductive system following chemotherapeutic treatment with cisplatin.
Materials and methods: This is a experimental study used 12 weeks old male Balb/c mice, divided into four groups. We observed significant reduction in the numbers of spermatocytes, spermatids, Sertoli cells, and Leydig cells in the testes following cisplatin treatment. We then used two different types of Hippo pathway modulators to treat cisplatin-induced testicular and sperm phenotypes: i) XMU-MP-1, which is a strong inhibitor of mammalian sterile 20-like kinase 1/2, and ii) TT-10, which stimulates yes-associated protein (YAP) activity. We performed the analysis using the GraphPad Prism software. If the data were regularly distributed, we would compare the means of the two groups using a parametric test called the Student's t-test. A non-parametric test (Mann-Whitney U test) was employed if the data were not regularly distributed.
Results: We found that treatment with XMU-MP-1 significantly increased Leydig cell numbers. However, there was no change in sperm phenotype despite a significant improvement in sperm motility. In contrast, TT-10 treatment improved sperm concentration and morphology, and increased Leydig cell number.
Conclusions: Our data suggest that pharmacological modulation of the Hippo/YAP pathway may improve sperm and testicular phenotypes in mice following treatment with chemotherapeutic agents, such as cisplatin.
Downloads
1. Dohle GR. Male infertility in cancer patients: Review of the literature. Int J Urol 2010; 17:327-31. DOI: https://doi.org/10.1111/j.1442-2042.2010.02484.x
2. Lee SH, Shin CH. Reduced male fertility in childhood cancer survivors. Ann Pediatr Endocrinol Metab 2013; 18:168. DOI: https://doi.org/10.6065/apem.2013.18.4.168
3. Ismail HY, Shaker NA, Hussein S, et al. Cisplatin-induced azoospermia and testicular damage ameliorated by adipose-derived mesenchymal stem cells. Biol Res 2023; 56:2.
4. Dasari S, Bernard Tchounwou P. Cisplatin in cancer therapy: Molecular mechanisms of action. Eur J Pharmacol 2014; 740:364-78. DOI: https://doi.org/10.1016/j.ejphar.2014.07.025
5. Tchounwou PB, Dasari S, Noubissi FK, et al. Advances in Our Understanding of the Molecular Mechanisms of Action of Cisplatin in Cancer Therapy. J Exp Pharmacol 2021; 13:303-28. DOI: https://doi.org/10.2147/JEP.S267383
6. Colpi GM, Contalbi GF, Nerva F, et al. Testicular function following chemo-radiotherapy. European Journal of Obstetrics & Gynecology and Reproductive Biology 2004; 113:S2-6. DOI: https://doi.org/10.1016/j.ejogrb.2003.11.002
7. Ma S, Meng Z, Chen R, Guan KL. The Hippo Pathway: Biology and Pathophysiology. Annu Rev Biochem 2019; 88:577-604. DOI: https://doi.org/10.1146/annurev-biochem-013118-111829
8. Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev 2016; 30:1-17. DOI: https://doi.org/10.1101/gad.274027.115
9. Hong W, Guan KL. The YAP and TAZ transcription co-activators: Key downstream effectors of the mammalian Hippo pathway. Semin Cell Dev Biol 2012; 23:785-93. DOI: https://doi.org/10.1016/j.semcdb.2012.05.004
10. Levasseur A, Paquet M, Boerboom D, Boyer A. Yes-associated protein and WW-containing transcription regulator 1 regulate the expression of sex-determining genes in Sertoli cells, but their inactivation does not cause sex reversal†. Biol Reprod 2017; 97:162-75. DOI: https://doi.org/10.1093/biolre/iox057
11. Sen Sharma S, Vats A, Majumdar S. Regulation of Hippo pathway components by FSH in testis. Reprod Biol 2019; 19:61-6. DOI: https://doi.org/10.1016/j.repbio.2019.01.003
12. Fan F, He Z, Kong LL, et al. Pharmacological targeting of kinases MST1 and MST2 augments tissue repair and regeneration. Sci Transl Med 2016; 8:352ra108.
13. BC Cancer Drug Manual Cisplatin [Internet]. 2019 [cited 2025 Sep 7]; Available from: http://www.bccancer.bc.ca/drug-databasesite/Drug%20Index/Cisplatin_monograph.pdf
14. Perše M, Veceric-Haler Ž. Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges. Biomed Res Int 2018; 2018:1-29. DOI: https://doi.org/10.1155/2018/1462802
15. Reddy KP, Madhu P, Reddy PS. Protective effects of resveratrol against cisplatin-induced testicular and epididymal toxicity in rats. Food Chem Toxicol 2016; 91:65-72. DOI: https://doi.org/10.1016/j.fct.2016.02.017
16. Atessahin A, Karahan I, Türk G, et al. Protective role of lycopene on cisplatin-induced changes in sperm characteristics, testicular damage and oxidative stress in rats. Reprod Toxicol 2006; 21:42-7. DOI: https://doi.org/10.1016/j.reprotox.2005.05.003
17. Hara H, Takeda N, Kondo M, et al. Discovery of a Small Molecule to Increase Cardiomyocytes and Protect the Heart After Ischemic Injury. JACC Basic Transl Sci 2018; 3:639-53. DOI: https://doi.org/10.1016/j.jacbts.2018.07.005
18. WHO. WHO laboratory manual for the examination and processing of human semen Sixth Edition. Geneva: 2021.
19. Russell L, Ettlin R, Sinha HA, Clegg E. Histological and histopathological evaluation of the testis. Clearwater, Florida: Cache River Press; 1990. 286 pages, $62.50. Reproductive Toxicology 1992; 6:457-60. DOI: https://doi.org/10.1016/0890-6238(92)90011-H
20. Faizah Z, Amanda B, Ashari FY, et al. Treatment with Mammalian Ste-20-like Kinase 1/2 (MST1/2) Inhibitor XMU-MP-1 Improves Glucose Tolerance in Streptozotocin-Induced Diabetes Mice. Molecules 2020; 25:4381. DOI: https://doi.org/10.3390/molecules25194381
21. Ismail HY, Shaker NA, Hussein S, et al. Cisplatin-induced azoospermia and testicular damage ameliorated by adipose-derived mesenchymal stem cells. Biol Res 2023; 56:2. DOI: https://doi.org/10.1186/s40659-022-00410-5
22. A.A. Aly H, G. Eid B. Cisplatin induced testicular damage through mitochondria mediated apoptosis, inflammation and oxidative stress in rats: impact of resveratrol. Endocr J 2020; 67:969-80. DOI: https://doi.org/10.1507/endocrj.EJ20-0149
23. Razavi S, Hashemi F, Khadivi F, et al. Improvement of Rat Sperm Chromatin Integrity and Spermatogenesis with Omega 3 following Bleomycin, Etoposide and Cisplatin Treatment. Nutr Cancer 2021; 73:514-22. DOI: https://doi.org/10.1080/01635581.2020.1757128
24. Choi YM, Kim HK, Shim W, et al. Mechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation. PLoS One 2015; 10:e0135083. DOI: https://doi.org/10.1371/journal.pone.0135083
25. Kleih M, Böpple K, Dong M, et al. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. Cell Death Dis 2019; 10:851. DOI: https://doi.org/10.1038/s41419-019-2081-4
26. Bui AD, Sharma R, Henkel R, Agarwal A. Reactive oxygen species impact on sperm DNA and its role in male infertility. Andrologia 2018; 50:e13012. DOI: https://doi.org/10.1111/and.13012
27. Mannucci A, Argento FR, Fini E, et al. The Impact of Oxidative Stress in Male Infertility. Front Mol Biosci. 2022 Jan 5; 8:799294. doi: 10.3389/fmolb.2021.799294. DOI: https://doi.org/10.3389/fmolb.2021.799294
28. França LR, Hess RA, Dufour JM, et al. The Sertoli cell: one hundred fifty years of beauty and plasticity. Andrology 2016; 4:189-212. DOI: https://doi.org/10.1111/andr.12165
29. Kjærner-Semb E, Ayllon F, Kleppe L, et al. Vgll3 and the Hippo pathway are regulated in Sertoli cells upon entry and during puberty in Atlantic salmon testis. Sci Rep 2018; 8:1912. DOI: https://doi.org/10.1038/s41598-018-20308-1
30. Triastuti E, Nugroho AB, Zi M, et al. Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU-MP-1, protects the heart against adverse effects during pressure overload. Br J Pharmacol 2019; 176:3956-71. DOI: https://doi.org/10.1111/bph.14795
31. Qiao C, Jiang P, Yuan X, et al. Mammalian STE20-like kinase-1/2 are activated in human platelets stimulated by collagen or thrombin and play a vital role in collagen-activated platelets. Thromb Res 2023; 221:83-91. DOI: https://doi.org/10.1016/j.thromres.2022.11.025
32. Zhou X, Wang H, Li D, et al. MST1/2 inhibitor XMU-MP-1 alleviates the injury induced by ionizing radiation in haematopoietic and intestinal system. J Cell Mol Med 2022; 26:1621-8. DOI: https://doi.org/10.1111/jcmm.17203
33. Bui TA, Stafford N, Oceandy D. Genetic and Pharmacological YAP Activation Induces Proliferation and Improves Survival in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Cells 2023; 12:2121. DOI: https://doi.org/10.3390/cells12172121
34. Chen W, Pretorius D, Zhou Y,, et al. TT-10-loaded nanoparticles promote cardiomyocyte proliferation and cardiac repair in a mouse model of myocardial infarction. JCI Insight. 2021; 6:e151987.
35. Ito M, Hara H, Takeda N, et al. Characterization of a small molecule that promotes cell cycle activation of human induced pluripotent stem cell-derived cardiomyocytes. J Mol Cell Cardiol 2019; 128:90-5. DOI: https://doi.org/10.1016/j.yjmcc.2019.01.020
36. Du X, Shi H, Li J, et al. Mst1/Mst2 Regulate Development and Function of Regulatory T Cells through Modulation of Foxo1/Foxo3 Stability in Autoimmune Disease. The Journal of Immunology 2014;192:1525-35. DOI: https://doi.org/10.4049/jimmunol.1301060
37. Yuan Z, Lehtinen MK, Merlo P, et al. Regulation of Neuronal Cell Death by MST1-FOXO1 Signaling. J Biol Chem 2009; 284:11285-92. DOI: https://doi.org/10.1074/jbc.M900461200
38. Cinar B, Fang PK, Lutchman M, et al. The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1. EMBO J 2007; 26:4523-34. DOI: https://doi.org/10.1038/sj.emboj.7601872
39. Lee EF, Smith NA, Soares da Costa TP, et al. Structural insights into BCL2 pro-survival protein interactions with the key autophagy regulator BECN1 following phosphorylation by STK4/MST1.Autophagy 2019; 15:785-95. DOI: https://doi.org/10.1080/15548627.2018.1564557
40. Zhang GM, Zhang TT, An SY, et al. Expression of Hippo signaling pathway components in Hu sheep male reproductive tract and spermatozoa. Theriogenology 2019; 126:239-48. DOI: https://doi.org/10.1016/j.theriogenology.2018.12.029
41. Kuser-Abali G, Alptekin A, Lewis M, et al. YAP1 and AR interactions contribute to the switch from androgen-dependent to castration- resistant growth in prostate cancer. Nat Commun 2015; 6:8126. DOI: https://doi.org/10.1038/ncomms9126
42. Seo WI, Park S, Gwak J, et al. Wnt signaling promotes androgenindependent prostate cancer cell proliferation through up-regulation of the hippo pathway effector YAP. Biochem Biophys Res Commun 2017; 486:1034-9. DOI: https://doi.org/10.1016/j.bbrc.2017.03.158
Ethics Approval
CRediT authorship contribution
ZF, JJ, CP, and MIL contributed to the conceptualization of the study. CP, BA, ZF, JJ, and MIL contributed to the methodology. CP, BA, ZF, JJ, MIL, and BH were involved in data collection and investigation. CP and BA performed the formal statistical analysis and interpretation of the data. CP, BA, and BH drafted the original manuscript. All authors contributed to the review and editing of the manuscript and approved the final submitted version.
Supporting Agencies
Data Availability Statement
All relevant data supporting the findings of this study are included in the article. The full raw dataset is available from the corresponding author upon reasonable request
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.